Several publications have highlighted that a mass spectrometry measurement of Aβ peptides is more reflective of cerebral Aβ than immunoassay methods.3,34 We also acknowledge that there is a range of diagnostic performance in different p-tau measurements in determining AD.2,35. Here, MAPT is linked to Alzheimer disease.